通过在药物组合物及包含LL - 37的生长培养基中包括成双层性极性脂质，具体为双半乳糖基甘油二酯，可降低LL - 37的细胞毒性作用。
The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37.
通过在药物组合物及包含LL - 37的生长培养基中包括成双层性极性脂质，具体为双半乳糖基甘油二酯，可降低LL - 37的细胞毒性作用。
The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37.
应用推荐